TY - JOUR
T1 - Collating the voice of people with autoimmune diseases
T2 - Methodology for the Third Phase of the COVAD Studies
AU - the COVAD Study Group
AU - Kadam, Esha
AU - Javaid, Mahnoor
AU - Sen, Parikshit
AU - Saha, Sreoshy
AU - Ziade, Nelly
AU - Day, Jessica
AU - Wincup, Chris
AU - Andreoli, Laura
AU - Parodis, Ioannis
AU - Tan, Ai Lyn
AU - Shinjo, Samuel Katsuyuki
AU - Dey, Dzifa
AU - Cavagna, Lorenzo
AU - Chatterjee, Tulika
AU - Knitza, Johannes
AU - Wang, Guochun
AU - Dalbeth, Nicola
AU - Velikova, Tsvetelina
AU - Battista, Simone
AU - Cheng, Karen
AU - Boyd, Peter
AU - Kobert, Linda
AU - Gracia-Ramos, Abraham Edgar
AU - Mittal, Srijan
AU - Makol, Ashima
AU - Gutiérrez, Carlos Enrique Toro
AU - Uribe, Carlo V.Caballero
AU - Kuwana, Masataka
AU - Burmester, Gerd Rüdiger
AU - Guillemin, Francis
AU - Nikiphorou, Elena
AU - Chinoy, Hector
AU - Aggarwal, Vikas
AU - Gupta, Latika
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/7
Y1 - 2024/7
N2 - Introduction: The growing recognition of holistic patient care highlights the various factors shaping the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measures, there is an emerging acknowledgment of the less-explored aspects, including subjective well-being, social determinants of health, comorbidities, mental health, and medication adherence. Moreover, digital health services have empowered patients to engage actively in decision-making alongside clinicians. To explore these domains within the context of AIRDs, the “Collating the Voice of People with Autoimmune Diseases” COVAD survey was conceived, a successor of the previous two COVAD surveys. In this document, we present the study protocol in comprehensive detail. Methods: The COVAD-3 survey is a cross-sectional patient self-reported e-survey incorporating multiple widely accepted scales/scores to assess various aspects of patients’ lifestyles objectively. To ensure the survey's accuracy and usability across diverse regions, it will be translated into multiple languages and subjected to rigorous vetting and pilot testing. It will be distributed by collaborators via online platforms and data will be collected from patients with AIRDs, and healthy individuals over eight months. Data analysis will focus on outcome measures related to various social, demographic, economic, and psychological factors. Conclusion: With the increasing awareness to adopt a holistic treatment approach encompassing all avenues of life, the COVAD-3 survey aims to gain valuable insights into the impact of social, demographic, economic, and psychological determinants of health on the subjective well-being in patients with AIRDs, which will contribute to a better understanding of their overall health and well-being.
AB - Introduction: The growing recognition of holistic patient care highlights the various factors shaping the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measures, there is an emerging acknowledgment of the less-explored aspects, including subjective well-being, social determinants of health, comorbidities, mental health, and medication adherence. Moreover, digital health services have empowered patients to engage actively in decision-making alongside clinicians. To explore these domains within the context of AIRDs, the “Collating the Voice of People with Autoimmune Diseases” COVAD survey was conceived, a successor of the previous two COVAD surveys. In this document, we present the study protocol in comprehensive detail. Methods: The COVAD-3 survey is a cross-sectional patient self-reported e-survey incorporating multiple widely accepted scales/scores to assess various aspects of patients’ lifestyles objectively. To ensure the survey's accuracy and usability across diverse regions, it will be translated into multiple languages and subjected to rigorous vetting and pilot testing. It will be distributed by collaborators via online platforms and data will be collected from patients with AIRDs, and healthy individuals over eight months. Data analysis will focus on outcome measures related to various social, demographic, economic, and psychological factors. Conclusion: With the increasing awareness to adopt a holistic treatment approach encompassing all avenues of life, the COVAD-3 survey aims to gain valuable insights into the impact of social, demographic, economic, and psychological determinants of health on the subjective well-being in patients with AIRDs, which will contribute to a better understanding of their overall health and well-being.
KW - Autoimmune diseases
KW - COVAD
KW - Digital health
KW - Quality of life
KW - Sociodemographic factors
KW - Survey
UR - http://www.scopus.com/inward/record.url?scp=85190373141&partnerID=8YFLogxK
U2 - 10.1007/s00296-024-05562-z
DO - 10.1007/s00296-024-05562-z
M3 - Article
AN - SCOPUS:85190373141
SN - 0172-8172
VL - 44
SP - 1233
EP - 1244
JO - Rheumatology International
JF - Rheumatology International
IS - 7
ER -